<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02338154</url>
  </required_header>
  <id_info>
    <org_study_id>2011-13</org_study_id>
    <nct_id>NCT02338154</nct_id>
  </id_info>
  <brief_title>EDWARDS INTUITY Valve System FOUNDATION Study</brief_title>
  <acronym>FOUNDATION</acronym>
  <official_title>Assessing Standard oF Care and Clinical Outcomes UsiNg the EDWARDS INTUITY VAlve SysTem in a European multI-center, Active, pOst-market surveillaNce Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edwards Lifesciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this active post-market surveillance study is to confirm the safety and
      effectiveness of the EDWARDS INTUITY Valve System in the study population.

      The objective is to evaluate cardiac performance characteristics and adverse events rates
      associated with the EDWARDS INTUITY Valve in patients undergoing AVR. The AVR surgical
      approach is either full or partial sternotomy or a right anterior thoracotomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aortic valve replacement with mechanical or biological heart valves is the treatment of
      choice for aortic valve stenosis. Over the past several years, life expectancy has increased
      in industrial nations, but this has been accompanied by a rising rate of elderly patients
      with multiple illnesses.

      Aortic stenosis remains the most common cause of adult valvular heart disease, the prevalence
      increasing with age. Average survival of patients treated conservatively has historically
      been reported as 2—5 years from the onset of symptoms. More recent studies have confirmed the
      dismal prognosis of severe aortic stenosis. Advanced age, reduced left ventricular ejection
      fraction, congestive heart failure and renal insufficiency appear to be independent
      predictors of reduced survival. Asymptomatic patients with very severe aortic stenosis also
      share a poor prognosis with a high event rate and a risk of rapid functional deterioration.
      Early surgery offers a therapeutic option to improve clinical outcomes via decreasing cardiac
      mortality and improving symptoms.

      Bioprostheses offer several advantages over mechanical bioprostheses, the most important
      being freedom from anticoagulation with a low rate of thromboembolic accidents.

      In response to clinical need and in support of advances in minimally invasive surgical
      approaches to conventional AVR, Edwards Lifesciences developed the EDWARDS INTUITY Valve
      System to achieve clinical benefits by reducing cardiopulmonary bypass and cross clamp times,
      while facilitating a less invasive approach to aortic valve replacement.

      The system includes the EDWARDS INTUITY Valve System, Model 8300A and the EDWARDS INTUITY
      Delivery System, Model 8300D; the valve is based on prior heart valve designs which have a
      long history of safety and effectiveness and have incorporated additional features designed
      to improve patient outcomes and safety.

      With only 3 guiding sutures and secure balloon expandable frame, the EDWARDS INTUITY Valve
      system is well suited for smaller incisions and tight access, with an emphasis on procedural
      efficiency within existing operating suite of the surgeon.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Subject's Average Time Spent on Cardiopulmonary Cross Clamp</measure>
    <time_frame>At time of surgery; an average of 1 hour</time_frame>
    <description>Cardiopulmonary cross clamp time is the amount of time that the patient's aorta (blood vessel) is clamped by a surgical instrument used in cardiac surgery. This allows the normal blood flow to be sent to an artificial heart and lung machine to keep it at a constant temperature and oxygen level.</description>
  </primary_outcome>
  <other_outcome>
    <measure>Subject's Average Time Spent on Cardiopulmonary Bypass</measure>
    <time_frame>At time of surgery; an average of 1.5 hours</time_frame>
    <description>Cardiopulmonary bypass time is the amount of time that the patient's blood circulates through an artificial heart and lung machine during cardiac surgery.</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject's Average Skin-to-skin Time</measure>
    <time_frame>At time of surgery; an average of 3.5 hours</time_frame>
    <description>The time from start of skin incision to end of skin closure.</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject's Device Technical Success</measure>
    <time_frame>At time of surgery</time_frame>
    <description>Device technical success is defined as the successful delivery and deployment of the aortic trial heart valve with the subject leaving the operating room (OR) with valve in place.</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject's Average Health Care Utilization</measure>
    <time_frame>Day of surgical procedure through discharge from the ICU and hospital, an average of 3 days and 11 days respectively.</time_frame>
    <description>The average amount of time the subjects spent in the intensive care unit and the average total length of hospital stay after their heart valve replacement procedure.</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject's New York Heart Association (NYHA) Functional Class Compared to Baseline</measure>
    <time_frame>30 days, 3 months, 1 year, 2 years</time_frame>
    <description>The New York Heart Association (NYHA) functional classification system relates symptoms to everyday activities and the patient's quality of life.
Class I. Patients with cardiac disease but without resulting limitation of physical activity.
Class II. Patients with cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest.
Class III. Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest.
Class IV. Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort.
Symptoms of heart failure or the anginal syndrome may be present even at rest.</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject's Average Score on the EQ-5D- Quality of Life Questionnaire Over Time</measure>
    <time_frame>Baseline, 3 months</time_frame>
    <description>The EQ-5D is a standardized questionnaire that asks subjects to rate themselves (no problems, some problems, extreme problems) on mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The scale is indexed and ranges from a minimum of 0.275 and a maximum of 1.000. A lower number indicates the participants experiences more problems and a higher number indicates the participants experiences fewer problems.</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject's Average Mean Gradient Measurements</measure>
    <time_frame>Baseline, discharge, 3 months, and 1 year</time_frame>
    <description>Mean gradient is the average flow of blood through the aortic valve measured in millimeters of mercury. Gradients are evaluated by echocardiography over time. Mean gradient values depend on the size and type of valve.</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject's Average Peak Gradients (mmHg) Measurements Over Time</measure>
    <time_frame>Baseline, discharge, 3 months, and 1 year</time_frame>
    <description>Peak gradient is the maximum value measured of flow of blood through the aortic valve as measured in millimeters of mercury. Gradients are evaluated by echocardiography over time.</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject's Average Effective Orifice Area Measurements</measure>
    <time_frame>Baseline, discharge, 3 months, 1 year</time_frame>
    <description>Effective orifice area represents the cross-sectional area of the blood flow downstream of the aortic valve. Effective orifice area is evaluated by echocardiography over time.</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject's Average Effective Orifice Area Index (EOAI) Measurements</measure>
    <time_frame>Baseline, Discharge, 3 months, 1 year</time_frame>
    <description>Effective orifice area index represents the minimal cross-sectional area of the blood flow downstream of the aortic valve divided by the person's body surface area. Effective orifice area index is evaluated by echocardiography over time.</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject's Average Performance Index Measurements</measure>
    <time_frame>Discharge, 3 Months, 1 Year</time_frame>
    <description>Performance index is defined as the subject's effective orifice area (the cross-sectional area of the blood flow downstream of the aortic valve) divided by the subject's native orifice area. Effective orifice area is evaluated by echocardiography over time.</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject's Average Left Ventricular Ejection Fraction (LVEF)</measure>
    <time_frame>Baseline, discharge, 3 months, 1 year</time_frame>
    <description>Ejection fraction is a measurement of the percentage of blood leaving your heart each time it contracts. Ejection fraction is evaluated by echocardiography over time. A normal left ventricular ejection fraction (LVEF) ranges from 55% to 70%.</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject's Amount of Aortic Valvular Regurgitation Over Time.</measure>
    <time_frame>Discharge, 3 months, 1 year</time_frame>
    <description>Aortic valvular regurgitation occurs when the aortic valve in the heart does not close tightly allowing some of the blood that was pumped out of the heart to leak back into it. Aortic valvular regurgitation is evaluated by echocardiography over time. It is assessed on a scale from 0 to 4, where 0 represents no regurgitation and 4 represents severe regurgitation.</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject's Amount of Paravalvular Leak Over Time.</measure>
    <time_frame>Discharge, 3 months, 1 year</time_frame>
    <description>Paravalvular leak refers to blood flowing through a channel between the implanted artificial valve and the cardiac tissue as a result of inappropriate sealing. Paravalvular leak is evaluated by echocardiography over time. It is assessed on a scale from minimum of 0 to maximum of 4, where 0 = no leak, 1 = a trace leak, 2 = a mild leak, 3 = a moderate leak, and 4 = a severe leak. Higher numbers on the scale show a worsening outcome.</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject's Average Cardiac Output Over Time</measure>
    <time_frame>Discharge, 3 months, 1 year</time_frame>
    <description>The amount of blood the heart pumps through the circulatory system in a minute.</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject's Average Cardiac Output Index</measure>
    <time_frame>Discharge, 3 Months, 1 Year</time_frame>
    <description>A hemodynamic parameter that relates the cardiac output (CO) from left ventricle in one minute to body surface area (BSA).</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject's Average Left Ventricular End-Diastolic Dimension</measure>
    <time_frame>Baseline, Discharge, 3 Months, 1 Year</time_frame>
    <description>The measurement of the heart's left ventricle at end diastole.</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject's Average Left Ventricular End-Systolic Dimension</measure>
    <time_frame>Baseline, Discharge, 3 Months, 1 Year</time_frame>
    <description>The measurement of the heart's left ventricle at end systole.</description>
  </other_outcome>
  <other_outcome>
    <measure>Left Ventricular End-diastolic Volume (LVEDV)</measure>
    <time_frame>Baseline, Discharge, 3 Months, 1 Year</time_frame>
    <description>Left Ventricular end-diastolic volume (LVEDV) is the amount of (volume) of blood in the left ventricle at end load or filling in (diastole) or the amount of blood in the ventricle just before systole.</description>
  </other_outcome>
  <other_outcome>
    <measure>Left Ventricular End-systolic Volume (LVESV)</measure>
    <time_frame>Baseline, Discharge, 3 Months, 1 Year</time_frame>
    <description>Left Ventricular end-systolic volume (LVESV) is the amount of (volume) of blood in the left ventricle at the end of the heart's contraction, or systole, and the beginning of filling, or diastole.</description>
  </other_outcome>
  <other_outcome>
    <measure>Percentage of Subjects With Early Adverse Events</measure>
    <time_frame>Events occurring within 30 days of procedure</time_frame>
    <description>Number of Subjects with early adverse events occurring within 30 days of procedure divided by the number of enrolled subjects times 100.</description>
  </other_outcome>
  <other_outcome>
    <measure>Percentage of Late Adverse Events Divided by Late Patient Years</measure>
    <time_frame>Events occurring &gt;= 31 days and up through 2 years post-implant</time_frame>
    <description>Number of late events divided by the total number of late patient years times 100. Late patient years are calculated from 31 days post-implant to the date of the last contact (follow up or adverse event).</description>
  </other_outcome>
  <enrollment type="Actual">516</enrollment>
  <condition>Aortic Valve Disease</condition>
  <condition>Aortic Stenosis</condition>
  <condition>Rapid Deployment Valves</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult subjects, age 18 or older, that have been diagnosed with aortic stenosis or
        stenosis-based insufficiency and are scheduled to undergo surgical aortic valve replacement
        are eligible for participation in this study. Study subjects shall be drawn from the
        general patient populations served by each investigational center. Candidates for this
        study must meet all of the following inclusion criteria and none of the exclusion criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is 18 years or older

          2. Subject presents with aortic stenosis or stenosis-based insufficiency of an aortic
             valve requiring a planned replacement of the native aortic valve or previously
             implanted aortic prosthesis.

          3. Subject has signed and dated the investigation informed consent forms prior to
             study-specific procedures are performed.

          4. Subject is geographically stable and agrees to attend follow-up assessments as
             specified in the protocol and informed consent.

        Exclusion Criteria:

          1. History of active endocarditis within three months of scheduled surgery

          2. Subject is diagnosed with pure aortic insufficiency

          3. Aneurysm of the aortic root and/or ascending aorta
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr. Glauber, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Organizational Affiliation: OSPEDALE &quot;G. PASQUINUCCI&quot; CREAS IFC-CNR</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Prof.Christopher Young, MD FRCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guy's &amp; St Thomas' Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Salzburger Universitätsklinikum</name>
      <address>
        <city>Salzburg</city>
        <zip>5020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Landesklinikum - St. Pölten</name>
      <address>
        <city>St Pölten</city>
        <zip>3100</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinisshe Abteiluing Für Herz-thoraxchirurgie</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aarhus Universitetshospital Skejby</name>
      <address>
        <city>Aarhus N</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Bocage Central Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21074</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Joseph - Marseille</name>
      <address>
        <city>Marseille Cedex</city>
        <zip>13285</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Mulhouse</name>
      <address>
        <city>Mulhouse Cedex</city>
        <zip>68051</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Cardiologique du Nord St Denis</name>
      <address>
        <city>St Denis</city>
        <zip>93200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herz- und Gefäß-Klinik GmbH Bad Neustadt</name>
      <address>
        <city>Bad Neustadt An Der Saale</city>
        <zip>97616</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westdeutsches Herzcentrum Uniklinik Essen</name>
      <address>
        <city>Essen</city>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Nürnberg Süd</name>
      <address>
        <city>Nürenberg</city>
        <zip>90471</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Santa Maria</name>
      <address>
        <city>Bari</city>
        <zip>70124</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>S. Anna Hospital</name>
      <address>
        <city>Catanzaro</city>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>G. Pasquinucci Heart Hospital - &quot;G.Monasterio&quot; Foundation</name>
      <address>
        <city>Massa</city>
        <zip>54100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Cardiologico Monzino</name>
      <address>
        <city>Milan</city>
        <zip>20138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Niguarda Ca' Granda</name>
      <address>
        <city>Milan</city>
        <zip>20162</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Università Cattolica del Sacro Cuore Policlinico</name>
      <address>
        <city>Roma</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria &quot;Santa Maria della Misericordia&quot;</name>
      <address>
        <city>Udine</city>
        <zip>33100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catharina Hospital Eindhoven</name>
      <address>
        <city>Eindhoven</city>
        <zip>5623</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de la Arrixaca</name>
      <address>
        <city>El Palmar</city>
        <state>Murcia</state>
        <zip>30120</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Cruces Barakaldo</name>
      <address>
        <city>Barakaldo</city>
        <zip>48903</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik Für Herz und Gefässchirurgie</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiocentro Ticino</name>
      <address>
        <city>Lugano</city>
        <zip>6903</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universität Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Thomas' Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King's College Hospital</name>
      <address>
        <city>London</city>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>https://professional.heart.org/professional/General/UCM_423811_Classification-of-Functional-Capacity-and-Objective-Assessment.jsp</url>
    <description>New York Heart Association Classification</description>
  </link>
  <link>
    <url>https://euroqol.org/eq-5d-instruments/</url>
    <description>EuroQol Standardized Instrument (EQ-5D) developed to measure of health-related quality of life</description>
  </link>
  <results_reference>
    <citation>Young C, Laufer G, Kocher A, Solinas M, Alamanni F, Polvani G, Podesser BK, Aramendi JI, Arribas J, Bouchot O, Livi U, Massetti M, Terp K, Giot C, Glauber M. One-year outcomes after rapid-deployment aortic valve replacement. J Thorac Cardiovasc Surg. 2018 Feb;155(2):575-585. doi: 10.1016/j.jtcvs.2017.09.133. Epub 2017 Oct 31.</citation>
    <PMID>29415382</PMID>
  </results_reference>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 19, 2014</study_first_submitted>
  <study_first_submitted_qc>January 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2015</study_first_posted>
  <results_first_submitted>August 30, 2019</results_first_submitted>
  <results_first_submitted_qc>September 23, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">October 14, 2019</results_first_posted>
  <last_update_submitted>November 12, 2019</last_update_submitted>
  <last_update_submitted_qc>November 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aortic Valve Replacement</keyword>
  <keyword>Aortic Stenosis</keyword>
  <keyword>EDWARDS INTUITY</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>516 Subjects were enrolled in this study, for which data is available.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>EDWARDS INTUITY Aortic Valve</title>
          <description>Aortic valve replacement therapy Heart Valve Surgery: The system includes the EDWARDS INTUITY Valve System, Model 8300A and the EDWARDS INTUITY Delivery System, Model 8300D</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="516"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Enrolled Cohort (Intent to Treat)</title>
              <participants_list>
                <participants group_id="P1" count="516"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>INTUITY (Study Valve Cohort)</title>
              <participants_list>
                <participants group_id="P1" count="493"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="373"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="143"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="46"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Valve Implant Failure</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Valve Explant</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject or by Investigator</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other Reason</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Patients Without Exit Form</title>
              <participants_list>
                <participants group_id="P1" count="47"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Missing Exit Reason on Exit Form</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Enrolled Cohort</title>
          <description>Subjects were considered enrolled into the clinical study when he/she signed the informed consent, met all the study eligibility criteria, and after the surgeon placed the first guiding suture on the bioprosthesis.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="516"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>The number analyzed is the number of patients with available data for the given parameter.</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="515"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75.5" spread="6.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Female</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="516"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="223"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="516"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="293"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <population>The number analyzed is the number of patients with available data for the given parameter.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="458"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="218"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="240"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <population>The number analyzed is the number of patients with available data for the given parameter.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="458"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="456"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Subject's Average Time Spent on Cardiopulmonary Cross Clamp</title>
        <description>Cardiopulmonary cross clamp time is the amount of time that the patient's aorta (blood vessel) is clamped by a surgical instrument used in cardiac surgery. This allows the normal blood flow to be sent to an artificial heart and lung machine to keep it at a constant temperature and oxygen level.</description>
        <time_frame>At time of surgery; an average of 1 hour</time_frame>
        <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>INTUITY (Study Valve Cohort)</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Time Spent on Cardiopulmonary Cross Clamp</title>
          <description>Cardiopulmonary cross clamp time is the amount of time that the patient's aorta (blood vessel) is clamped by a surgical instrument used in cardiac surgery. This allows the normal blood flow to be sent to an artificial heart and lung machine to keep it at a constant temperature and oxygen level.</description>
          <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="476"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.7" spread="24.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's Average Time Spent on Cardiopulmonary Bypass</title>
        <description>Cardiopulmonary bypass time is the amount of time that the patient's blood circulates through an artificial heart and lung machine during cardiac surgery.</description>
        <time_frame>At time of surgery; an average of 1.5 hours</time_frame>
        <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>INTUITY (Study Valve Cohort)</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Time Spent on Cardiopulmonary Bypass</title>
          <description>Cardiopulmonary bypass time is the amount of time that the patient's blood circulates through an artificial heart and lung machine during cardiac surgery.</description>
          <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="474"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.9" spread="33.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's Average Skin-to-skin Time</title>
        <description>The time from start of skin incision to end of skin closure.</description>
        <time_frame>At time of surgery; an average of 3.5 hours</time_frame>
        <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>INTUITY (Study Valve Cohort)</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Skin-to-skin Time</title>
          <description>The time from start of skin incision to end of skin closure.</description>
          <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
          <units>Minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="478"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="199.3" spread="69.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's Device Technical Success</title>
        <description>Device technical success is defined as the successful delivery and deployment of the aortic trial heart valve with the subject leaving the operating room (OR) with valve in place.</description>
        <time_frame>At time of surgery</time_frame>
        <population>The outcome is reported for subjects where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>Enrolled Cohort</title>
            <description>Subject were considered enrolled into the clinical study when he/she signed the informed consent, met all the study eligibility criteria, and after the surgeon placed the first guiding suture on the bioprosthesis.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Device Technical Success</title>
          <description>Device technical success is defined as the successful delivery and deployment of the aortic trial heart valve with the subject leaving the operating room (OR) with valve in place.</description>
          <population>The outcome is reported for subjects where data is available.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="516"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="493"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's Average Health Care Utilization</title>
        <description>The average amount of time the subjects spent in the intensive care unit and the average total length of hospital stay after their heart valve replacement procedure.</description>
        <time_frame>Day of surgical procedure through discharge from the ICU and hospital, an average of 3 days and 11 days respectively.</time_frame>
        <population>The outcome is reported for subjects where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>Enrolled Cohort</title>
            <description>Subject were considered enrolled into the clinical study when he/she signed the informed consent, met all the study eligibility criteria, and after the surgeon placed the first guiding suture on the bioprosthesis.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Health Care Utilization</title>
          <description>The average amount of time the subjects spent in the intensive care unit and the average total length of hospital stay after their heart valve replacement procedure.</description>
          <population>The outcome is reported for subjects where data is available.</population>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="516"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>ICU Length of Stay</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="492"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8" spread="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hospital Length of Stay</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="507"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.2" spread="18.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's New York Heart Association (NYHA) Functional Class Compared to Baseline</title>
        <description>The New York Heart Association (NYHA) functional classification system relates symptoms to everyday activities and the patient's quality of life.
Class I. Patients with cardiac disease but without resulting limitation of physical activity.
Class II. Patients with cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest.
Class III. Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest.
Class IV. Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort.
Symptoms of heart failure or the anginal syndrome may be present even at rest.</description>
        <time_frame>30 days, 3 months, 1 year, 2 years</time_frame>
        <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>INTUITY (Study Valve Cohort)</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's New York Heart Association (NYHA) Functional Class Compared to Baseline</title>
          <description>The New York Heart Association (NYHA) functional classification system relates symptoms to everyday activities and the patient's quality of life.
Class I. Patients with cardiac disease but without resulting limitation of physical activity.
Class II. Patients with cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest.
Class III. Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest.
Class IV. Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort.
Symptoms of heart failure or the anginal syndrome may be present even at rest.</description>
          <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="493"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 Days</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="418"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="272"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Same</title>
                  <measurement_list>
                    <measurement group_id="O1" value="129"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Worsened</title>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="433"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="326"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Same</title>
                  <measurement_list>
                    <measurement group_id="O1" value="99"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Worsened</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="364"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="293"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Same</title>
                  <measurement_list>
                    <measurement group_id="O1" value="63"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Worsened</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 Year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="350"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="255"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Same</title>
                  <measurement_list>
                    <measurement group_id="O1" value="80"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Worsened</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's Average Score on the EQ-5D- Quality of Life Questionnaire Over Time</title>
        <description>The EQ-5D is a standardized questionnaire that asks subjects to rate themselves (no problems, some problems, extreme problems) on mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The scale is indexed and ranges from a minimum of 0.275 and a maximum of 1.000. A lower number indicates the participants experiences more problems and a higher number indicates the participants experiences fewer problems.</description>
        <time_frame>Baseline, 3 months</time_frame>
        <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>INTUITY (Study Valve Cohort)</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Score on the EQ-5D- Quality of Life Questionnaire Over Time</title>
          <description>The EQ-5D is a standardized questionnaire that asks subjects to rate themselves (no problems, some problems, extreme problems) on mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The scale is indexed and ranges from a minimum of 0.275 and a maximum of 1.000. A lower number indicates the participants experiences more problems and a higher number indicates the participants experiences fewer problems.</description>
          <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="493"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="172"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.818" spread="0.137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="162"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.864" spread="0.149"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline to 3 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="157"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.040" spread="0.131"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's Average Mean Gradient Measurements</title>
        <description>Mean gradient is the average flow of blood through the aortic valve measured in millimeters of mercury. Gradients are evaluated by echocardiography over time. Mean gradient values depend on the size and type of valve.</description>
        <time_frame>Baseline, discharge, 3 months, and 1 year</time_frame>
        <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>INTUITY (Study Valve Cohort) - 19mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O2">
            <title>INTUITY (Study Valve Cohort) - 21mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O3">
            <title>INTUITY (Study Valve Cohort) - 23mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O4">
            <title>INTUITY (Study Valve Cohort) - 25mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O5">
            <title>INTUITY (Study Valve Cohort) - 27mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O6">
            <title>INTUITY (Study Valve Cohort) - Overall</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Mean Gradient Measurements</title>
          <description>Mean gradient is the average flow of blood through the aortic valve measured in millimeters of mercury. Gradients are evaluated by echocardiography over time. Mean gradient values depend on the size and type of valve.</description>
          <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="134"/>
                <count group_id="O3" value="157"/>
                <count group_id="O4" value="92"/>
                <count group_id="O5" value="30"/>
                <count group_id="O6" value="486"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="67"/>
                    <count group_id="O2" value="117"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="85"/>
                    <count group_id="O5" value="25"/>
                    <count group_id="O6" value="435"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.22" spread="21.24"/>
                    <measurement group_id="O2" value="49.11" spread="16.81"/>
                    <measurement group_id="O3" value="47.51" spread="16.70"/>
                    <measurement group_id="O4" value="44.36" spread="13.33"/>
                    <measurement group_id="O5" value="44.83" spread="14.79"/>
                    <measurement group_id="O6" value="47.74" spread="16.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="69"/>
                    <count group_id="O2" value="126"/>
                    <count group_id="O3" value="139"/>
                    <count group_id="O4" value="84"/>
                    <count group_id="O5" value="27"/>
                    <count group_id="O6" value="445"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.83" spread="8.35"/>
                    <measurement group_id="O2" value="11.74" spread="6.42"/>
                    <measurement group_id="O3" value="10.69" spread="5.98"/>
                    <measurement group_id="O4" value="10.69" spread="7.65"/>
                    <measurement group_id="O5" value="7.77" spread="2.96"/>
                    <measurement group_id="O6" value="11.61" spread="7.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="62"/>
                    <count group_id="O2" value="107"/>
                    <count group_id="O3" value="133"/>
                    <count group_id="O4" value="82"/>
                    <count group_id="O5" value="26"/>
                    <count group_id="O6" value="410"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.58" spread="8.26"/>
                    <measurement group_id="O2" value="10.96" spread="6.01"/>
                    <measurement group_id="O3" value="9.73" spread="5.98"/>
                    <measurement group_id="O4" value="8.34" spread="4.68"/>
                    <measurement group_id="O5" value="7.38" spread="2.80"/>
                    <measurement group_id="O6" value="10.36" spread="6.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="50"/>
                    <count group_id="O2" value="91"/>
                    <count group_id="O3" value="110"/>
                    <count group_id="O4" value="67"/>
                    <count group_id="O5" value="28"/>
                    <count group_id="O6" value="346"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.16" spread="6.90"/>
                    <measurement group_id="O2" value="10.14" spread="4.28"/>
                    <measurement group_id="O3" value="8.96" spread="3.72"/>
                    <measurement group_id="O4" value="8.45" spread="3.03"/>
                    <measurement group_id="O5" value="7.25" spread="3.13"/>
                    <measurement group_id="O6" value="9.64" spread="4.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's Average Peak Gradients (mmHg) Measurements Over Time</title>
        <description>Peak gradient is the maximum value measured of flow of blood through the aortic valve as measured in millimeters of mercury. Gradients are evaluated by echocardiography over time.</description>
        <time_frame>Baseline, discharge, 3 months, and 1 year</time_frame>
        <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>INTUITY (Study Valve Cohort) - 19mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O2">
            <title>INTUITY (Study Valve Cohort) - 21mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O3">
            <title>INTUITY (Study Valve Cohort) - 23mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O4">
            <title>INTUITY (Study Valve Cohort) - 25mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O5">
            <title>INTUITY (Study Valve Cohort) - 27mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O6">
            <title>INTUITY (Study Valve Cohort) - Overall</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Peak Gradients (mmHg) Measurements Over Time</title>
          <description>Peak gradient is the maximum value measured of flow of blood through the aortic valve as measured in millimeters of mercury. Gradients are evaluated by echocardiography over time.</description>
          <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="134"/>
                <count group_id="O3" value="157"/>
                <count group_id="O4" value="92"/>
                <count group_id="O5" value="30"/>
                <count group_id="O6" value="486"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="67"/>
                    <count group_id="O2" value="119"/>
                    <count group_id="O3" value="144"/>
                    <count group_id="O4" value="86"/>
                    <count group_id="O5" value="25"/>
                    <count group_id="O6" value="441"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.75" spread="33.17"/>
                    <measurement group_id="O2" value="78.92" spread="28.21"/>
                    <measurement group_id="O3" value="77.08" spread="25.15"/>
                    <measurement group_id="O4" value="73.11" spread="20.92"/>
                    <measurement group_id="O5" value="72.51" spread="21.22"/>
                    <measurement group_id="O6" value="77.56" spread="26.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="69"/>
                    <count group_id="O2" value="126"/>
                    <count group_id="O3" value="141"/>
                    <count group_id="O4" value="85"/>
                    <count group_id="O5" value="28"/>
                    <count group_id="O6" value="449"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.42" spread="12.83"/>
                    <measurement group_id="O2" value="21.88" spread="10.53"/>
                    <measurement group_id="O3" value="20.29" spread="9.75"/>
                    <measurement group_id="O4" value="19.78" spread="12.28"/>
                    <measurement group_id="O5" value="14.00" spread="5.63"/>
                    <measurement group_id="O6" value="21.65" spread="11.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="62"/>
                    <count group_id="O2" value="109"/>
                    <count group_id="O3" value="134"/>
                    <count group_id="O4" value="82"/>
                    <count group_id="O5" value="26"/>
                    <count group_id="O6" value="413"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.46" spread="13.64"/>
                    <measurement group_id="O2" value="21.12" spread="10.32"/>
                    <measurement group_id="O3" value="19.48" spread="11.90"/>
                    <measurement group_id="O4" value="16.52" spread="7.82"/>
                    <measurement group_id="O5" value="14.00" spread="4.96"/>
                    <measurement group_id="O6" value="20.18" spread="11.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="50"/>
                    <count group_id="O2" value="93"/>
                    <count group_id="O3" value="109"/>
                    <count group_id="O4" value="69"/>
                    <count group_id="O5" value="28"/>
                    <count group_id="O6" value="349"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.88" spread="8.57"/>
                    <measurement group_id="O2" value="18.29" spread="7.17"/>
                    <measurement group_id="O3" value="16.97" spread="6.77"/>
                    <measurement group_id="O4" value="15.40" spread="4.94"/>
                    <measurement group_id="O5" value="13.29" spread="5.37"/>
                    <measurement group_id="O6" value="17.70" spread="7.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's Average Effective Orifice Area Measurements</title>
        <description>Effective orifice area represents the cross-sectional area of the blood flow downstream of the aortic valve. Effective orifice area is evaluated by echocardiography over time.</description>
        <time_frame>Baseline, discharge, 3 months, 1 year</time_frame>
        <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY valve where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>INTUITY (Study Valve Cohort) - 19mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O2">
            <title>INTUITY (Study Valve Cohort) - 21mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O3">
            <title>INTUITY (Study Valve Cohort) - 23mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O4">
            <title>INTUITY (Study Valve Cohort) - 25mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O5">
            <title>INTUITY (Study Valve Cohort) - 27mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O6">
            <title>INTUITY (Study Valve Cohort) - Overall</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Effective Orifice Area Measurements</title>
          <description>Effective orifice area represents the cross-sectional area of the blood flow downstream of the aortic valve. Effective orifice area is evaluated by echocardiography over time.</description>
          <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY valve where data is available.</population>
          <units>Centimeters squared</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="134"/>
                <count group_id="O3" value="157"/>
                <count group_id="O4" value="92"/>
                <count group_id="O5" value="30"/>
                <count group_id="O6" value="486"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="59"/>
                    <count group_id="O2" value="108"/>
                    <count group_id="O3" value="132"/>
                    <count group_id="O4" value="78"/>
                    <count group_id="O5" value="20"/>
                    <count group_id="O6" value="397"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.62" spread="0.16"/>
                    <measurement group_id="O2" value="0.71" spread="0.29"/>
                    <measurement group_id="O3" value="0.75" spread="0.34"/>
                    <measurement group_id="O4" value="0.74" spread="0.26"/>
                    <measurement group_id="O5" value="0.81" spread="0.25"/>
                    <measurement group_id="O6" value="0.72" spread="0.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="58"/>
                    <count group_id="O2" value="99"/>
                    <count group_id="O3" value="122"/>
                    <count group_id="O4" value="68"/>
                    <count group_id="O5" value="20"/>
                    <count group_id="O6" value="367"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.17" spread="0.41"/>
                    <measurement group_id="O2" value="1.66" spread="0.53"/>
                    <measurement group_id="O3" value="2.00" spread="0.64"/>
                    <measurement group_id="O4" value="2.18" spread="0.70"/>
                    <measurement group_id="O5" value="2.83" spread="0.90"/>
                    <measurement group_id="O6" value="1.86" spread="0.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="56"/>
                    <count group_id="O2" value="99"/>
                    <count group_id="O3" value="119"/>
                    <count group_id="O4" value="77"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="375"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.14" spread="0.39"/>
                    <measurement group_id="O2" value="1.59" spread="0.52"/>
                    <measurement group_id="O3" value="1.86" spread="0.62"/>
                    <measurement group_id="O4" value="2.10" spread="0.59"/>
                    <measurement group_id="O5" value="2.54" spread="0.77"/>
                    <measurement group_id="O6" value="1.77" spread="0.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="83"/>
                    <count group_id="O3" value="98"/>
                    <count group_id="O4" value="60"/>
                    <count group_id="O5" value="26"/>
                    <count group_id="O6" value="312"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.28" spread="0.33"/>
                    <measurement group_id="O2" value="1.61" spread="0.43"/>
                    <measurement group_id="O3" value="1.97" spread="0.42"/>
                    <measurement group_id="O4" value="2.23" spread="0.65"/>
                    <measurement group_id="O5" value="2.64" spread="0.73"/>
                    <measurement group_id="O6" value="1.88" spread="0.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's Average Effective Orifice Area Index (EOAI) Measurements</title>
        <description>Effective orifice area index represents the minimal cross-sectional area of the blood flow downstream of the aortic valve divided by the person's body surface area. Effective orifice area index is evaluated by echocardiography over time.</description>
        <time_frame>Baseline, Discharge, 3 months, 1 year</time_frame>
        <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY valve where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>INUTITY (Study Valve Cohort) - 19mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O2">
            <title>INTUITY (Study Valve Cohort) - 21mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O3">
            <title>INTUITY (Study Valve Cohort) - 23mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O4">
            <title>INTUITY (Study Valve Cohort) - 25mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O5">
            <title>INTUITY (Study Valve Cohort) - 27mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O6">
            <title>INTUITY (Study Valve Cohort) - Overall</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Effective Orifice Area Index (EOAI) Measurements</title>
          <description>Effective orifice area index represents the minimal cross-sectional area of the blood flow downstream of the aortic valve divided by the person's body surface area. Effective orifice area index is evaluated by echocardiography over time.</description>
          <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY valve where data is available.</population>
          <units>centimeters squared/meters squared</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="134"/>
                <count group_id="O3" value="157"/>
                <count group_id="O4" value="92"/>
                <count group_id="O5" value="30"/>
                <count group_id="O6" value="486"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="59"/>
                    <count group_id="O2" value="108"/>
                    <count group_id="O3" value="129"/>
                    <count group_id="O4" value="78"/>
                    <count group_id="O5" value="20"/>
                    <count group_id="O6" value="394"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.37" spread="0.10"/>
                    <measurement group_id="O2" value="0.41" spread="0.18"/>
                    <measurement group_id="O3" value="0.40" spread="0.17"/>
                    <measurement group_id="O4" value="0.37" spread="0.14"/>
                    <measurement group_id="O5" value="0.40" spread="0.12"/>
                    <measurement group_id="O6" value="0.39" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="49"/>
                    <count group_id="O2" value="79"/>
                    <count group_id="O3" value="94"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="294"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.69" spread="0.26"/>
                    <measurement group_id="O2" value="0.92" spread="0.31"/>
                    <measurement group_id="O3" value="1.05" spread="0.34"/>
                    <measurement group_id="O4" value="1.15" spread="0.35"/>
                    <measurement group_id="O5" value="1.40" spread="0.50"/>
                    <measurement group_id="O6" value="0.99" spread="0.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="87"/>
                    <count group_id="O3" value="89"/>
                    <count group_id="O4" value="58"/>
                    <count group_id="O5" value="20"/>
                    <count group_id="O6" value="302"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.69" spread="0.24"/>
                    <measurement group_id="O2" value="0.91" spread="0.31"/>
                    <measurement group_id="O3" value="0.99" spread="0.40"/>
                    <measurement group_id="O4" value="1.09" spread="0.34"/>
                    <measurement group_id="O5" value="1.23" spread="0.42"/>
                    <measurement group_id="O6" value="0.96" spread="0.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="79"/>
                    <count group_id="O3" value="94"/>
                    <count group_id="O4" value="52"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="287"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.76" spread="0.21"/>
                    <measurement group_id="O2" value="0.92" spread="0.26"/>
                    <measurement group_id="O3" value="1.06" spread="0.22"/>
                    <measurement group_id="O4" value="1.13" spread="0.33"/>
                    <measurement group_id="O5" value="1.30" spread="0.48"/>
                    <measurement group_id="O6" value="1.01" spread="0.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's Average Performance Index Measurements</title>
        <description>Performance index is defined as the subject's effective orifice area (the cross-sectional area of the blood flow downstream of the aortic valve) divided by the subject's native orifice area. Effective orifice area is evaluated by echocardiography over time.</description>
        <time_frame>Discharge, 3 Months, 1 Year</time_frame>
        <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY valve where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>INUTITY (Study Valve Cohort) - 19mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O2">
            <title>INTUITY (Study Valve Cohort) - 21mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O3">
            <title>INTUITY (Study Valve Cohort) - 23mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O4">
            <title>INTUITY (Study Valve Cohort) - 25mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O5">
            <title>INTUITY (Study Valve Cohort) - 27mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O6">
            <title>INTUITY (Study Valve Cohort) - Overall</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Performance Index Measurements</title>
          <description>Performance index is defined as the subject's effective orifice area (the cross-sectional area of the blood flow downstream of the aortic valve) divided by the subject's native orifice area. Effective orifice area is evaluated by echocardiography over time.</description>
          <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY valve where data is available.</population>
          <units>cm^2/cm^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="134"/>
                <count group_id="O3" value="157"/>
                <count group_id="O4" value="92"/>
                <count group_id="O5" value="30"/>
                <count group_id="O6" value="486"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="97"/>
                    <count group_id="O3" value="103"/>
                    <count group_id="O4" value="69"/>
                    <count group_id="O5" value="22"/>
                    <count group_id="O6" value="345"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.44" spread="0.12"/>
                    <measurement group_id="O2" value="0.49" spread="0.13"/>
                    <measurement group_id="O3" value="0.53" spread="0.14"/>
                    <measurement group_id="O4" value="0.49" spread="0.12"/>
                    <measurement group_id="O5" value="0.56" spread="0.12"/>
                    <measurement group_id="O6" value="0.50" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="87"/>
                    <count group_id="O3" value="104"/>
                    <count group_id="O4" value="72"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="332"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.44" spread="0.12"/>
                    <measurement group_id="O2" value="0.50" spread="0.12"/>
                    <measurement group_id="O3" value="0.55" spread="0.13"/>
                    <measurement group_id="O4" value="0.52" spread="0.13"/>
                    <measurement group_id="O5" value="0.57" spread="0.13"/>
                    <measurement group_id="O6" value="0.52" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="75"/>
                    <count group_id="O3" value="89"/>
                    <count group_id="O4" value="56"/>
                    <count group_id="O5" value="22"/>
                    <count group_id="O6" value="287"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.48" spread="0.12"/>
                    <measurement group_id="O2" value="0.51" spread="0.14"/>
                    <measurement group_id="O3" value="0.55" spread="0.12"/>
                    <measurement group_id="O4" value="0.53" spread="0.13"/>
                    <measurement group_id="O5" value="0.58" spread="0.13"/>
                    <measurement group_id="O6" value="0.53" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's Average Left Ventricular Ejection Fraction (LVEF)</title>
        <description>Ejection fraction is a measurement of the percentage of blood leaving your heart each time it contracts. Ejection fraction is evaluated by echocardiography over time. A normal left ventricular ejection fraction (LVEF) ranges from 55% to 70%.</description>
        <time_frame>Baseline, discharge, 3 months, 1 year</time_frame>
        <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>INTUITY (Study Valve Cohort) - 19mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O2">
            <title>INTUITY (Study Valve Cohort) - 21mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O3">
            <title>INTUITY (Study Valve Cohort) - 23mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O4">
            <title>INTUITY (Study Valve Cohort) - 25mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O5">
            <title>INTUITY (Study Valve Cohort) - 27mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O6">
            <title>INTUITY (Study Valve Cohort) - Overall</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Left Ventricular Ejection Fraction (LVEF)</title>
          <description>Ejection fraction is a measurement of the percentage of blood leaving your heart each time it contracts. Ejection fraction is evaluated by echocardiography over time. A normal left ventricular ejection fraction (LVEF) ranges from 55% to 70%.</description>
          <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
          <units>Percentage of blood</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="134"/>
                <count group_id="O3" value="157"/>
                <count group_id="O4" value="92"/>
                <count group_id="O5" value="30"/>
                <count group_id="O6" value="486"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="66"/>
                    <count group_id="O2" value="112"/>
                    <count group_id="O3" value="134"/>
                    <count group_id="O4" value="83"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="418"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.71" spread="9.85"/>
                    <measurement group_id="O2" value="65.87" spread="11.89"/>
                    <measurement group_id="O3" value="64.56" spread="11.73"/>
                    <measurement group_id="O4" value="60.57" spread="12.85"/>
                    <measurement group_id="O5" value="62.96" spread="9.29"/>
                    <measurement group_id="O6" value="64.37" spread="11.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="66"/>
                    <count group_id="O2" value="113"/>
                    <count group_id="O3" value="132"/>
                    <count group_id="O4" value="74"/>
                    <count group_id="O5" value="25"/>
                    <count group_id="O6" value="410"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.05" spread="11.40"/>
                    <measurement group_id="O2" value="64.16" spread="11.63"/>
                    <measurement group_id="O3" value="65.87" spread="10.70"/>
                    <measurement group_id="O4" value="60.45" spread="12.57"/>
                    <measurement group_id="O5" value="61.12" spread="13.36"/>
                    <measurement group_id="O6" value="64.16" spread="11.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="57"/>
                    <count group_id="O2" value="105"/>
                    <count group_id="O3" value="128"/>
                    <count group_id="O4" value="81"/>
                    <count group_id="O5" value="26"/>
                    <count group_id="O6" value="397"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.58" spread="6.96"/>
                    <measurement group_id="O2" value="66.26" spread="9.88"/>
                    <measurement group_id="O3" value="65.20" spread="9.51"/>
                    <measurement group_id="O4" value="62.36" spread="11.29"/>
                    <measurement group_id="O5" value="63.08" spread="10.24"/>
                    <measurement group_id="O6" value="64.67" spread="9.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="76"/>
                    <count group_id="O3" value="93"/>
                    <count group_id="O4" value="62"/>
                    <count group_id="O5" value="22"/>
                    <count group_id="O6" value="293"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.28" spread="8.12"/>
                    <measurement group_id="O2" value="64.64" spread="8.23"/>
                    <measurement group_id="O3" value="64.65" spread="8.98"/>
                    <measurement group_id="O4" value="63.30" spread="7.75"/>
                    <measurement group_id="O5" value="63.64" spread="9.35"/>
                    <measurement group_id="O6" value="64.23" spread="8.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's Amount of Aortic Valvular Regurgitation Over Time.</title>
        <description>Aortic valvular regurgitation occurs when the aortic valve in the heart does not close tightly allowing some of the blood that was pumped out of the heart to leak back into it. Aortic valvular regurgitation is evaluated by echocardiography over time. It is assessed on a scale from 0 to 4, where 0 represents no regurgitation and 4 represents severe regurgitation.</description>
        <time_frame>Discharge, 3 months, 1 year</time_frame>
        <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>INTUITY (Study Valve Cohort) - 19mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O2">
            <title>INTUITY (Study Valve Cohort) - 21mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O3">
            <title>INTUITY (Study Valve Cohort) - 23mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O4">
            <title>INTUITY (Study Valve Cohort) - 25mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O5">
            <title>INTUITY (Study Valve Cohort) - 27mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O6">
            <title>INTUITY (Study Valve Cohort) - Overall</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Amount of Aortic Valvular Regurgitation Over Time.</title>
          <description>Aortic valvular regurgitation occurs when the aortic valve in the heart does not close tightly allowing some of the blood that was pumped out of the heart to leak back into it. Aortic valvular regurgitation is evaluated by echocardiography over time. It is assessed on a scale from 0 to 4, where 0 represents no regurgitation and 4 represents severe regurgitation.</description>
          <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="134"/>
                <count group_id="O3" value="157"/>
                <count group_id="O4" value="92"/>
                <count group_id="O5" value="30"/>
                <count group_id="O6" value="486"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="68"/>
                    <count group_id="O2" value="118"/>
                    <count group_id="O3" value="134"/>
                    <count group_id="O4" value="78"/>
                    <count group_id="O5" value="26"/>
                    <count group_id="O6" value="429"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>0 None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="69"/>
                    <measurement group_id="O3" value="83"/>
                    <measurement group_id="O4" value="52"/>
                    <measurement group_id="O5" value="19"/>
                    <measurement group_id="O6" value="260"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+1 Trivial/Trace</title>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                    <measurement group_id="O2" value="39"/>
                    <measurement group_id="O3" value="42"/>
                    <measurement group_id="O4" value="22"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="140"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+2 Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="28"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+3 Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+4 Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="61"/>
                    <count group_id="O2" value="116"/>
                    <count group_id="O3" value="137"/>
                    <count group_id="O4" value="83"/>
                    <count group_id="O5" value="30"/>
                    <count group_id="O6" value="430"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>0 None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="67"/>
                    <measurement group_id="O3" value="80"/>
                    <measurement group_id="O4" value="55"/>
                    <measurement group_id="O5" value="21"/>
                    <measurement group_id="O6" value="249"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+1 Trivial/Trace</title>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="39"/>
                    <measurement group_id="O3" value="43"/>
                    <measurement group_id="O4" value="24"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="144"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+2 Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="28"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+3 Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+4 Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="50"/>
                    <count group_id="O2" value="93"/>
                    <count group_id="O3" value="116"/>
                    <count group_id="O4" value="69"/>
                    <count group_id="O5" value="28"/>
                    <count group_id="O6" value="358"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>0 None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                    <measurement group_id="O2" value="60"/>
                    <measurement group_id="O3" value="78"/>
                    <measurement group_id="O4" value="49"/>
                    <measurement group_id="O5" value="18"/>
                    <measurement group_id="O6" value="236"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+1 Trivial/Trace</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O3" value="21"/>
                    <measurement group_id="O4" value="17"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="85"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+2 Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+3 Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+4 Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's Amount of Paravalvular Leak Over Time.</title>
        <description>Paravalvular leak refers to blood flowing through a channel between the implanted artificial valve and the cardiac tissue as a result of inappropriate sealing. Paravalvular leak is evaluated by echocardiography over time. It is assessed on a scale from minimum of 0 to maximum of 4, where 0 = no leak, 1 = a trace leak, 2 = a mild leak, 3 = a moderate leak, and 4 = a severe leak. Higher numbers on the scale show a worsening outcome.</description>
        <time_frame>Discharge, 3 months, 1 year</time_frame>
        <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>INTUITY (Study Valve Cohort) - 19mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O2">
            <title>INTUITY (Study Valve Cohort) - 21mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O3">
            <title>INTUITY (Study Valve Cohort) - 23mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O4">
            <title>INTUITY (Study Valve Cohort) - 25mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O5">
            <title>INTUITY (Study Valve Cohort) - 27mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O6">
            <title>INTUITY (Study Valve Cohort) - Overall</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Amount of Paravalvular Leak Over Time.</title>
          <description>Paravalvular leak refers to blood flowing through a channel between the implanted artificial valve and the cardiac tissue as a result of inappropriate sealing. Paravalvular leak is evaluated by echocardiography over time. It is assessed on a scale from minimum of 0 to maximum of 4, where 0 = no leak, 1 = a trace leak, 2 = a mild leak, 3 = a moderate leak, and 4 = a severe leak. Higher numbers on the scale show a worsening outcome.</description>
          <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="134"/>
                <count group_id="O3" value="157"/>
                <count group_id="O4" value="92"/>
                <count group_id="O5" value="30"/>
                <count group_id="O6" value="486"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="67"/>
                    <count group_id="O2" value="118"/>
                    <count group_id="O3" value="137"/>
                    <count group_id="O4" value="79"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="430"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>0 None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="99"/>
                    <measurement group_id="O3" value="105"/>
                    <measurement group_id="O4" value="69"/>
                    <measurement group_id="O5" value="22"/>
                    <measurement group_id="O6" value="358"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+1 Trivial/Trace</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="25"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="55"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+2 Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+3 Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+4 Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="60"/>
                    <count group_id="O2" value="110"/>
                    <count group_id="O3" value="130"/>
                    <count group_id="O4" value="82"/>
                    <count group_id="O5" value="28"/>
                    <count group_id="O6" value="413"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>0 None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="52"/>
                    <measurement group_id="O2" value="84"/>
                    <measurement group_id="O3" value="96"/>
                    <measurement group_id="O4" value="67"/>
                    <measurement group_id="O5" value="22"/>
                    <measurement group_id="O6" value="324"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+1 Trivial/Trace</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="20"/>
                    <measurement group_id="O3" value="22"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="63"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+2 Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+3 Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+4 Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="83"/>
                    <count group_id="O3" value="96"/>
                    <count group_id="O4" value="65"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="313"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>0 None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="64"/>
                    <measurement group_id="O3" value="65"/>
                    <measurement group_id="O4" value="56"/>
                    <measurement group_id="O5" value="20"/>
                    <measurement group_id="O6" value="238"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+1 Trivial/Trace</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="16"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="53"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+2 Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+3 Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>+4 Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's Average Cardiac Output Over Time</title>
        <description>The amount of blood the heart pumps through the circulatory system in a minute.</description>
        <time_frame>Discharge, 3 months, 1 year</time_frame>
        <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY valve where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>INTUITY (Study Valve Cohort) - 19mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O2">
            <title>INTUITY (Study Valve Cohort) - 21mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O3">
            <title>INTUITY (Study Valve Cohort) - 23mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O4">
            <title>INTUITY (Study Valve Cohort) - 25mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O5">
            <title>INTUITY (Study Valve Cohort) - 27mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O6">
            <title>INTUITY (Study Valve Cohort) - Overall</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Cardiac Output Over Time</title>
          <description>The amount of blood the heart pumps through the circulatory system in a minute.</description>
          <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY valve where data is available.</population>
          <units>liters per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="134"/>
                <count group_id="O3" value="157"/>
                <count group_id="O4" value="92"/>
                <count group_id="O5" value="30"/>
                <count group_id="O6" value="486"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="94"/>
                    <count group_id="O3" value="106"/>
                    <count group_id="O4" value="67"/>
                    <count group_id="O5" value="20"/>
                    <count group_id="O6" value="341"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.14" spread="1.39"/>
                    <measurement group_id="O2" value="4.24" spread="1.31"/>
                    <measurement group_id="O3" value="4.60" spread="1.33"/>
                    <measurement group_id="O4" value="4.74" spread="1.48"/>
                    <measurement group_id="O5" value="5.09" spread="1.82"/>
                    <measurement group_id="O6" value="4.49" spread="1.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="88"/>
                    <count group_id="O3" value="104"/>
                    <count group_id="O4" value="74"/>
                    <count group_id="O5" value="20"/>
                    <count group_id="O6" value="333"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.85" spread="1.40"/>
                    <measurement group_id="O2" value="4.36" spread="1.15"/>
                    <measurement group_id="O3" value="4.29" spread="1.12"/>
                    <measurement group_id="O4" value="4.16" spread="1.19"/>
                    <measurement group_id="O5" value="5.08" spread="1.57"/>
                    <measurement group_id="O6" value="4.26" spread="1.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="75"/>
                    <count group_id="O3" value="89"/>
                    <count group_id="O4" value="56"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="285"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.86" spread="1.28"/>
                    <measurement group_id="O2" value="4.26" spread="1.11"/>
                    <measurement group_id="O3" value="4.61" spread="1.30"/>
                    <measurement group_id="O4" value="4.61" spread="1.30"/>
                    <measurement group_id="O5" value="5.90" spread="1.76"/>
                    <measurement group_id="O6" value="4.50" spread="1.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's Average Cardiac Output Index</title>
        <description>A hemodynamic parameter that relates the cardiac output (CO) from left ventricle in one minute to body surface area (BSA).</description>
        <time_frame>Discharge, 3 Months, 1 Year</time_frame>
        <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY valve where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>INTUITY (Study Valve Cohort) - 19mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O2">
            <title>INTUITY (Study Valve Cohort) - 21mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O3">
            <title>INTUITY (Study Valve Cohort) - 23mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O4">
            <title>INTUITY (Study Valve Cohort) - 25mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O5">
            <title>INTUITY (Study Valve Cohort) - 27mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O6">
            <title>INTUITY (Study Valve Cohort) - Overall</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Cardiac Output Index</title>
          <description>A hemodynamic parameter that relates the cardiac output (CO) from left ventricle in one minute to body surface area (BSA).</description>
          <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY valve where data is available.</population>
          <units>L/min/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="134"/>
                <count group_id="O3" value="157"/>
                <count group_id="O4" value="92"/>
                <count group_id="O5" value="30"/>
                <count group_id="O6" value="486"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="73"/>
                    <count group_id="O3" value="79"/>
                    <count group_id="O4" value="53"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="268"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.45" spread="0.89"/>
                    <measurement group_id="O2" value="2.40" spread="0.79"/>
                    <measurement group_id="O3" value="2.44" spread="0.75"/>
                    <measurement group_id="O4" value="2.54" spread="0.72"/>
                    <measurement group_id="O5" value="2.45" spread="0.77"/>
                    <measurement group_id="O6" value="2.45" spread="0.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="77"/>
                    <count group_id="O3" value="77"/>
                    <count group_id="O4" value="53"/>
                    <count group_id="O5" value="19"/>
                    <count group_id="O6" value="265"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.40" spread="0.88"/>
                    <measurement group_id="O2" value="2.54" spread="0.67"/>
                    <measurement group_id="O3" value="2.33" spread="0.62"/>
                    <measurement group_id="O4" value="2.21" spread="0.65"/>
                    <measurement group_id="O5" value="2.61" spread="1.00"/>
                    <measurement group_id="O6" value="2.40" spread="0.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="72"/>
                    <count group_id="O3" value="85"/>
                    <count group_id="O4" value="48"/>
                    <count group_id="O5" value="16"/>
                    <count group_id="O6" value="261"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.32" spread="0.81"/>
                    <measurement group_id="O2" value="2.47" spread="0.68"/>
                    <measurement group_id="O3" value="2.49" spread="0.71"/>
                    <measurement group_id="O4" value="2.32" spread="0.65"/>
                    <measurement group_id="O5" value="2.88" spread="1.09"/>
                    <measurement group_id="O6" value="2.45" spread="0.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's Average Left Ventricular End-Diastolic Dimension</title>
        <description>The measurement of the heart's left ventricle at end diastole.</description>
        <time_frame>Baseline, Discharge, 3 Months, 1 Year</time_frame>
        <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY valve where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>INTUITY (Study Valve Cohort) - 19mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O2">
            <title>INTUITY (Study Valve Cohort) - 21mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O3">
            <title>INTUITY (Study Valve Cohort) - 23mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O4">
            <title>INTUITY (Study Valve Cohort) - 25mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O5">
            <title>INTUITY (Study Valve Cohort) - 27mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O6">
            <title>INTUITY (Study Valve Cohort) - Overall</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Left Ventricular End-Diastolic Dimension</title>
          <description>The measurement of the heart's left ventricle at end diastole.</description>
          <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY valve where data is available.</population>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="134"/>
                <count group_id="O3" value="157"/>
                <count group_id="O4" value="92"/>
                <count group_id="O5" value="30"/>
                <count group_id="O6" value="486"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="53"/>
                    <count group_id="O2" value="106"/>
                    <count group_id="O3" value="121"/>
                    <count group_id="O4" value="74"/>
                    <count group_id="O5" value="17"/>
                    <count group_id="O6" value="371"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.05" spread="0.58"/>
                    <measurement group_id="O2" value="4.30" spread="0.74"/>
                    <measurement group_id="O3" value="4.38" spread="0.63"/>
                    <measurement group_id="O4" value="4.76" spread="0.72"/>
                    <measurement group_id="O5" value="4.92" spread="0.67"/>
                    <measurement group_id="O6" value="4.41" spread="0.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="80"/>
                    <count group_id="O3" value="98"/>
                    <count group_id="O4" value="56"/>
                    <count group_id="O5" value="19"/>
                    <count group_id="O6" value="293"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.92" spread="0.67"/>
                    <measurement group_id="O2" value="4.09" spread="0.68"/>
                    <measurement group_id="O3" value="4.35" spread="0.65"/>
                    <measurement group_id="O4" value="4.51" spread="0.73"/>
                    <measurement group_id="O5" value="4.67" spread="1.30"/>
                    <measurement group_id="O6" value="4.27" spread="0.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="86"/>
                    <count group_id="O3" value="102"/>
                    <count group_id="O4" value="71"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="323"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.93" spread="0.59"/>
                    <measurement group_id="O2" value="4.17" spread="0.59"/>
                    <measurement group_id="O3" value="4.25" spread="0.62"/>
                    <measurement group_id="O4" value="4.55" spread="0.68"/>
                    <measurement group_id="O5" value="4.88" spread="0.79"/>
                    <measurement group_id="O6" value="4.29" spread="0.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="62"/>
                    <count group_id="O3" value="75"/>
                    <count group_id="O4" value="49"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="245"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.98" spread="0.64"/>
                    <measurement group_id="O2" value="4.08" spread="0.71"/>
                    <measurement group_id="O3" value="4.43" spread="0.54"/>
                    <measurement group_id="O4" value="4.47" spread="0.72"/>
                    <measurement group_id="O5" value="4.72" spread="0.64"/>
                    <measurement group_id="O6" value="4.30" spread="0.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject's Average Left Ventricular End-Systolic Dimension</title>
        <description>The measurement of the heart's left ventricle at end systole.</description>
        <time_frame>Baseline, Discharge, 3 Months, 1 Year</time_frame>
        <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY valve where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>INTUITY (Study Valve Cohort) - 19mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O2">
            <title>INTUITY (Study Valve Cohort) - 21mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O3">
            <title>INTUITY (Study Valve Cohort) - 23mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O4">
            <title>INTUITY (Study Valve Cohort) - 25mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O5">
            <title>INTUITY (Study Valve Cohort) - 27mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O6">
            <title>INTUITY (Study Valve Cohort) - Overall</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject's Average Left Ventricular End-Systolic Dimension</title>
          <description>The measurement of the heart's left ventricle at end systole.</description>
          <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY valve where data is available.</population>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="134"/>
                <count group_id="O3" value="157"/>
                <count group_id="O4" value="92"/>
                <count group_id="O5" value="30"/>
                <count group_id="O6" value="486"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="53"/>
                    <count group_id="O2" value="104"/>
                    <count group_id="O3" value="118"/>
                    <count group_id="O4" value="73"/>
                    <count group_id="O5" value="17"/>
                    <count group_id="O6" value="365"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.63" spread="0.60"/>
                    <measurement group_id="O2" value="2.80" spread="0.75"/>
                    <measurement group_id="O3" value="2.99" spread="0.72"/>
                    <measurement group_id="O4" value="3.29" spread="0.91"/>
                    <measurement group_id="O5" value="3.36" spread="0.82"/>
                    <measurement group_id="O6" value="2.96" spread="0.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="80"/>
                    <count group_id="O3" value="97"/>
                    <count group_id="O4" value="54"/>
                    <count group_id="O5" value="19"/>
                    <count group_id="O6" value="290"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.60" spread="0.65"/>
                    <measurement group_id="O2" value="2.80" spread="0.73"/>
                    <measurement group_id="O3" value="2.97" spread="0.69"/>
                    <measurement group_id="O4" value="3.07" spread="0.70"/>
                    <measurement group_id="O5" value="3.32" spread="0.84"/>
                    <measurement group_id="O6" value="2.92" spread="0.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="86"/>
                    <count group_id="O3" value="102"/>
                    <count group_id="O4" value="71"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="323"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.53" spread="0.56"/>
                    <measurement group_id="O2" value="2.70" spread="0.62"/>
                    <measurement group_id="O3" value="2.81" spread="0.56"/>
                    <measurement group_id="O4" value="3.02" spread="0.67"/>
                    <measurement group_id="O5" value="3.31" spread="0.75"/>
                    <measurement group_id="O6" value="2.82" spread="0.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="62"/>
                    <count group_id="O3" value="74"/>
                    <count group_id="O4" value="49"/>
                    <count group_id="O5" value="20"/>
                    <count group_id="O6" value="243"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.63" spread="0.61"/>
                    <measurement group_id="O2" value="2.69" spread="0.69"/>
                    <measurement group_id="O3" value="2.90" spread="0.54"/>
                    <measurement group_id="O4" value="2.91" spread="0.68"/>
                    <measurement group_id="O5" value="3.06" spread="0.68"/>
                    <measurement group_id="O6" value="2.82" spread="0.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Left Ventricular End-diastolic Volume (LVEDV)</title>
        <description>Left Ventricular end-diastolic volume (LVEDV) is the amount of (volume) of blood in the left ventricle at end load or filling in (diastole) or the amount of blood in the ventricle just before systole.</description>
        <time_frame>Baseline, Discharge, 3 Months, 1 Year</time_frame>
        <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY valve where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>INUTITY (Study Valve Cohort) - 19mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O2">
            <title>INTUITY (Study Valve Cohort) - 21mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O3">
            <title>INTUITY (Study Valve Cohort) - 23mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O4">
            <title>INTUITY (Study Valve Cohort) - 25mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O5">
            <title>INTUITY (Study Valve Cohort) - 27mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O6">
            <title>INTUITY (Study Valve Cohort) - Overall</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
        </group_list>
        <measure>
          <title>Left Ventricular End-diastolic Volume (LVEDV)</title>
          <description>Left Ventricular end-diastolic volume (LVEDV) is the amount of (volume) of blood in the left ventricle at end load or filling in (diastole) or the amount of blood in the ventricle just before systole.</description>
          <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY valve where data is available.</population>
          <units>milliliters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="134"/>
                <count group_id="O3" value="157"/>
                <count group_id="O4" value="92"/>
                <count group_id="O5" value="30"/>
                <count group_id="O6" value="486"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="62"/>
                    <count group_id="O2" value="108"/>
                    <count group_id="O3" value="125"/>
                    <count group_id="O4" value="78"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="394"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.68" spread="23.55"/>
                    <measurement group_id="O2" value="75.17" spread="27.76"/>
                    <measurement group_id="O3" value="83.52" spread="31.17"/>
                    <measurement group_id="O4" value="101.91" spread="33.55"/>
                    <measurement group_id="O5" value="109.90" spread="41.78"/>
                    <measurement group_id="O6" value="83.00" spread="33.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="61"/>
                    <count group_id="O2" value="109"/>
                    <count group_id="O3" value="118"/>
                    <count group_id="O4" value="71"/>
                    <count group_id="O5" value="22"/>
                    <count group_id="O6" value="381"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.90" spread="20.35"/>
                    <measurement group_id="O2" value="63.26" spread="24.58"/>
                    <measurement group_id="O3" value="70.93" spread="24.61"/>
                    <measurement group_id="O4" value="82.10" spread="30.54"/>
                    <measurement group_id="O5" value="102.27" spread="39.83"/>
                    <measurement group_id="O6" value="69.74" spread="28.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="92"/>
                    <count group_id="O3" value="112"/>
                    <count group_id="O4" value="77"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="353"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.96" spread="24.76"/>
                    <measurement group_id="O2" value="64.89" spread="20.44"/>
                    <measurement group_id="O3" value="74.94" spread="23.96"/>
                    <measurement group_id="O4" value="91.66" spread="32.80"/>
                    <measurement group_id="O5" value="93.42" spread="31.21"/>
                    <measurement group_id="O6" value="74.78" spread="28.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="63"/>
                    <count group_id="O3" value="76"/>
                    <count group_id="O4" value="51"/>
                    <count group_id="O5" value="19"/>
                    <count group_id="O6" value="245"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.86" spread="21.22"/>
                    <measurement group_id="O2" value="72.46" spread="22.17"/>
                    <measurement group_id="O3" value="79.12" spread="26.37"/>
                    <measurement group_id="O4" value="85.80" spread="27.47"/>
                    <measurement group_id="O5" value="86.47" spread="31.99"/>
                    <measurement group_id="O6" value="76.69" spread="26.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Left Ventricular End-systolic Volume (LVESV)</title>
        <description>Left Ventricular end-systolic volume (LVESV) is the amount of (volume) of blood in the left ventricle at the end of the heart's contraction, or systole, and the beginning of filling, or diastole.</description>
        <time_frame>Baseline, Discharge, 3 Months, 1 Year</time_frame>
        <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY valve where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>INUTITY (Study Valve Cohort) - 19mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O2">
            <title>INTUITY (Study Valve Cohort) - 21mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O3">
            <title>INTUITY (Study Valve Cohort) - 23mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O4">
            <title>INTUITY (Study Valve Cohort) - 25mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O5">
            <title>INTUITY (Study Valve Cohort) - 27mm</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
          <group group_id="O6">
            <title>INTUITY (Study Valve Cohort) - Overall</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
        </group_list>
        <measure>
          <title>Left Ventricular End-systolic Volume (LVESV)</title>
          <description>Left Ventricular end-systolic volume (LVESV) is the amount of (volume) of blood in the left ventricle at the end of the heart's contraction, or systole, and the beginning of filling, or diastole.</description>
          <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY valve where data is available.</population>
          <units>milliliters</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="134"/>
                <count group_id="O3" value="157"/>
                <count group_id="O4" value="92"/>
                <count group_id="O5" value="30"/>
                <count group_id="O6" value="486"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="62"/>
                    <count group_id="O2" value="108"/>
                    <count group_id="O3" value="125"/>
                    <count group_id="O4" value="78"/>
                    <count group_id="O5" value="21"/>
                    <count group_id="O6" value="394"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22" spread="13.47"/>
                    <measurement group_id="O2" value="27.50" spread="18.97"/>
                    <measurement group_id="O3" value="30.46" spread="19.03"/>
                    <measurement group_id="O4" value="42.36" spread="26.74"/>
                    <measurement group_id="O5" value="40.76" spread="24.75"/>
                    <measurement group_id="O6" value="31.22" spread="21.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discharge</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="61"/>
                    <count group_id="O2" value="109"/>
                    <count group_id="O3" value="118"/>
                    <count group_id="O4" value="71"/>
                    <count group_id="O5" value="22"/>
                    <count group_id="O6" value="381"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.57" spread="12.38"/>
                    <measurement group_id="O2" value="23.90" spread="15.69"/>
                    <measurement group_id="O3" value="24.51" spread="13.95"/>
                    <measurement group_id="O4" value="33.27" spread="19.96"/>
                    <measurement group_id="O5" value="41.36" spread="27.97"/>
                    <measurement group_id="O6" value="25.99" spread="17.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="92"/>
                    <count group_id="O3" value="112"/>
                    <count group_id="O4" value="77"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="353"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.10" spread="10.93"/>
                    <measurement group_id="O2" value="22.33" spread="13.05"/>
                    <measurement group_id="O3" value="26.17" spread="14.66"/>
                    <measurement group_id="O4" value="35.77" spread="22.99"/>
                    <measurement group_id="O5" value="35.50" spread="19.66"/>
                    <measurement group_id="O6" value="27.07" spread="17.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="63"/>
                    <count group_id="O3" value="76"/>
                    <count group_id="O4" value="51"/>
                    <count group_id="O5" value="19"/>
                    <count group_id="O6" value="245"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.86" spread="9.28"/>
                    <measurement group_id="O2" value="26.62" spread="12.57"/>
                    <measurement group_id="O3" value="28.37" spread="14.15"/>
                    <measurement group_id="O4" value="32.00" spread="13.02"/>
                    <measurement group_id="O5" value="31.68" spread="19.08"/>
                    <measurement group_id="O6" value="27.98" spread="13.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Percentage of Subjects With Early Adverse Events</title>
        <description>Number of Subjects with early adverse events occurring within 30 days of procedure divided by the number of enrolled subjects times 100.</description>
        <time_frame>Events occurring within 30 days of procedure</time_frame>
        <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>INTUITY (Study Valve Cohort)</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects With Early Adverse Events</title>
          <description>Number of Subjects with early adverse events occurring within 30 days of procedure divided by the number of enrolled subjects times 100.</description>
          <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
          <units>Percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="493"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>All cause mortality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Study valve-related mortality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thromboembolic events</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Study valve thrombosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bleeding event</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All paravalvular leak</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Major paravalvular leak (Moderate or Severe)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Endocarditis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Structural valve deterioration</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-structural valve deterioration (other than PVL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hemolysis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Reoperation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Explant</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>New and worsening conduction disturbance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Percentage of Late Adverse Events Divided by Late Patient Years</title>
        <description>Number of late events divided by the total number of late patient years times 100. Late patient years are calculated from 31 days post-implant to the date of the last contact (follow up or adverse event).</description>
        <time_frame>Events occurring &gt;= 31 days and up through 2 years post-implant</time_frame>
        <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
        <group_list>
          <group group_id="O1">
            <title>INTUITY (Study Valve Cohort)</title>
            <description>The study valve cohort consists of all patients that left the operating room with the study valve in place.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Late Adverse Events Divided by Late Patient Years</title>
          <description>Number of late events divided by the total number of late patient years times 100. Late patient years are calculated from 31 days post-implant to the date of the last contact (follow up or adverse event).</description>
          <population>This outcome is reported for subjects who received a Model 8300A Edwards INTUITY Valve where data is available.</population>
          <units>Percentage of events/late patient years</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="493"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>All cause mortality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Study valve-related mortality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thromboembolic events</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Study valve thrombosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bleeding event</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All Paravalvular Leak</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Major paravalvular leak (Moderate or Severe)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Endocarditis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Structural valve deterioration</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-structural valve deterioration (other than PVL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hemolysis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Reoperation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Explant</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>New and worsening conduction disturbance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Events occurring from baseline through two (2) years post implant</time_frame>
      <desc>Adverse event table is reported using Enrolled Cohort. Where an adverse event term below includes the word “Other”, those adverse events were unable to be classified into a more specific adverse event category.</desc>
      <group_list>
        <group group_id="E1">
          <title>Enrolled Cohort</title>
          <description>Subject's were considered enrolled into the clinical study when he/she signed the informed consent, met all the study eligibility criteria, and after the surgeon places the first guiding suture on the bioprosthesis.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="46" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="245" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia - Bleeding related - Major</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Anemia - Bleeding related - Minor</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Anemia - Non-bleeding related</sub_title>
                <counts group_id="E1" events="13" subjects_affected="10" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Bleeding - Cardiovascular - Major</sub_title>
                <counts group_id="E1" events="18" subjects_affected="16" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Bleeding - Cardiovascular - Minor</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Bleeding - Gastrointestinal upper -Major</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Bleeding - Gastrointestinal upper -Minor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Bleeding - Neurological - Major (e.g. CVA)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Bleeding - Pulmonary/Respiratory - Major (e.g. hemothorax)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Blood Sepsis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Blood/ Lymphatic - Other</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina, Stable</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Angina, Unstable</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Arrhythmia - AV Block - 1st degree</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Arrhythmia - AV Block - 2nd degree</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Arrhythmia - AV Block - 3rd degree</sub_title>
                <counts group_id="E1" events="25" subjects_affected="25" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Atrial Flutter</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Bradycardia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Bundle Branch Block - Left</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Other</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Paroxysmal Atrial Fibrillation (PAF)</sub_title>
                <counts group_id="E1" events="39" subjects_affected="34" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Permanent Atrial Fibrillation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Persistant Atrial Fibrillaiton</sub_title>
                <counts group_id="E1" events="12" subjects_affected="9" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Tachycardia - Ventricular</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Ventricular Fibrillation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Cardiac Arrest</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Cardiac Decompensation</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Cardiogenic Shock</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Cardiovascular - Other</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Heart Failure - Acute</sub_title>
                <counts group_id="E1" events="11" subjects_affected="9" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Heart Failure - Chronic (CHF)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Hypertension - Systemic</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Perforation - Atrial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Perforation - Other</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion - Major</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion - Minor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Pericardial Tamponade - Major</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Pleural Effusion - Bilateral</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Pleural Effusion - Left</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Pleural Effusion - Right</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Regurgitation - Aortic-Central/Transvalvular-+3</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Regurgitation - Aortic-Central/Transvalvular-+4</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Regurgitation - Aortic-Indeterminate-+2</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Regurgitation - Aortic-Indeterminate-+4</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Thromboembolic Event - Other - Central - Hemiparesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Thromboembolic Event - Other - Peripheral - No paresis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Thromboembolic Event - Stroke</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Thromboembolic Event - Transient Ischemic Attack (TIA)</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Valve Thrombosis - Aortic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Biliary (Gallbladder)</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Gastrointestinal - Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Gastrointestinal - Other</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Pancreatic complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic Reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Cancer - Newly diagnosed</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Cancer - Progression of underlying disease</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Multi-System organ failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>NSD - Paravalvular Leak - +2</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>NSD - Paravalvular Leak - +3</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>NSD - Paravalvular Leak - +4</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Nonspecific, Unknown, or Other Body System - Other complication</sub_title>
                <counts group_id="E1" events="18" subjects_affected="17" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Speech disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>NSD - Paravalvular leak with Hemolysis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hepatic complication - Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Liver Failure - Acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection /Inflammation - Other</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Bone Fracture/Break</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Muscular Skeletal / Dermatologic - Other</sub_title>
                <counts group_id="E1" events="18" subjects_affected="17" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Sternal Wound/Thoracic Infection</sub_title>
                <counts group_id="E1" events="10" subjects_affected="8" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>SVD - Stent frame separation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Psychiatric - Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Psychiatric Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Suicide</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Genitourinary - Other</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Renal Dysfunction</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Renal Failure - Acute</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Renal Failure - Chronic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection (UTI)</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Pulmonary Edema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolism - Bilateral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolism - Right</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Pulmonary/Respiratory - Other</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Respiratory Dysfunction/Insufficiency</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Respiratory Failure -COPD</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Respiratory Failure -Other</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Respiratory Failure -Pneumonia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Respiratory Failure -Pneumothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Respiratory Infection - Pneumonia</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Respiratory Infection - Upper (URI)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Respiratory Failure -Acute Respiratory Distress Syndrome (ARDS)</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Vascular - Other</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="157" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia - Bleeding related - Major</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Anemia - Bleeding related - Minor</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Anemia - Non-bleeding related</sub_title>
                <counts group_id="E1" events="13" subjects_affected="12" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Bleeding - Cardiovascular - Minor</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Bleeding - Gastrointestinal lower -Minor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Bleeding - Gastrointestinal upper -Minor</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Bleeding - Genitourinary - Minor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Bleeding - Peripheral vascular - Minor (e.g. nosebleeds; hematomas)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Blood/ Lymphatic - Other</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia - Non-Heparin Induced</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina, Stable</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Arrhythmia - AV Block - 1st degree</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Arrhythmia - AV Block - 3rd degree</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Bundle Branch Block - Left</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Bundle Branch Block - Right</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Paroxysmal Atrial Fibrillation (PAF)</sub_title>
                <counts group_id="E1" events="47" subjects_affected="46" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Permanent Atrial Fibrillation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Persistant Atrial Fibrillaiton</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Arrhythmia - Tachycardia - Ventricular</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Cardiovascular - Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Heart Failure - Chronic (CHF)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Hypertension - Systemic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion - Minor</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Thromboembolic Event - Other - Peripheral - Hemiparesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Thromboembolic Event - Stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Thromboembolic Event - Transient Ischemic Attack (TIA)</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Endocrine complications</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Vision disorder</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Biliary (Gallbladder)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Gastrointestinal - Other</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic Reaction - Medication related</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Cancer - Newly diagnosed</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>NSD - Paravalvular Leak - +2</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>NSD - Paravalvular leak with Hemolysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Nonspecific, Unknown, or Other Body System - Other complication</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hepatic complication - Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection /Inflammation - Other</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Wound Infection - Other</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Bone Fracture/Break</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Muscular Skeletal / Dermatologic - Other</sub_title>
                <counts group_id="E1" events="15" subjects_affected="14" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Sternal Wound/Thoracic Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Psychiatric - Other</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Psychiatric Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Transient Psychotic Syndrome</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal Dysfunction</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Renal Failure - Acute</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection (UTI)</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pleural Effusion - Bilateral</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Pleural Effusion - Left</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Pulmonary/Respiratory - Other</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Respiratory Dysfunction/Insufficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Respiratory Failure -COPD</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Respiratory Infection - Pneumonia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Respiratory Infection - Upper (URI)</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Vascular - Deep Vein Thrombosis (DVT)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
              <event>
                <sub_title>Vascular - Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="516"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Publication of overall study results which have not been released requires written approval of Sponsor, but presentation of site-specific results can occur subject to review by Sponsor. Manuscripts will be submitted to Sponsor for review 30 days prior to submission of manuscript for publication/presentation. Sponsor may ask for a 60 day delay of submission of manuscripts for publication to protect proprietary information and filing of related patent applications.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart</name_or_title>
      <organization>Edwards Lifesciences, LLC</organization>
      <phone>949-250-2500 ext 0225</phone>
      <email>Andrey_Nersesov@edwards.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

